Home
/
Records
/
145
/
Morton Drug Company

145

•Morton Drug Company•June 13, 2019

FDA 145 - Morton Drug Company - June 13, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This 145 record concerns Morton Drug Company, with an inspection on June 13, 2019, covering drugs.

Company: Morton Drug Company
Inspection Date: June 13, 2019
Product Type: Drugs
Person: Nicholas F. Lyons (Director of Compliance)

Open in Dashboard

ID · afa352d0-49ae-47f7-bf11-ac7638be4e80

Violation Codes5

21 CFR 21021 CFR 211FD&C Act 801(a)(3)21 CFR 331(c)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA 145 - Morton Drug Company - June 13, 2019 | Global Key Solutions